Epidrum for Thoracic Epidural Analgesia (Epidrum-Tho)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Hopital Foch
Sponsor:
Information provided by (Responsible Party):
Hopital Foch
ClinicalTrials.gov Identifier:
NCT01597466
First received: May 5, 2012
Last updated: November 9, 2013
Last verified: November 2013
  Purpose

The purpose of this study is to evaluate the use of the Epidrum device to identify the epidural space in patients requiring thoracic epidural analgesia.


Condition Intervention
Pain
Device: Epidural catheter placement
Procedure: Epidural catheter placement

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: A Comparison Study of Two Different Techniques for Identifying the Epidural Space in Patients Requiring Thoracic Epidural Analgesia: a Prospective Multicentric Randomized Study

Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • Ease to identify the epidural space [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
    Number of cases having required more than 2 punctures and number of failures of the technique


Secondary Outcome Measures:
  • Duration of epidural procedure [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
  • Number of cutaneous punctures [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
  • Number of needle redirections [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
  • Ease of epidural catheter insertion [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
  • Number of inadequate postoperative analgesia [ Time Frame: one day after anesthesia ] [ Designated as safety issue: No ]
    asymmetric, incomplete or failed analgesia


Estimated Enrollment: 120
Study Start Date: April 2013
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Epidrum
Epidrum (Exmoor Innovations, Lisieux Way, Taunton, Somerset TA1 2LB, U.K.)
Device: Epidural catheter placement
Epidural space is located using Epidrum (Exmoor Innovations, Lisieux Way, Taunton, Somerset TA1 2LB, U.K.)
Active Comparator: Loss of resistance technique Procedure: Epidural catheter placement
Epidural space is located using loss of resistance technique (saline solution)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Elective major thoracic surgery requiring thoracic epidural analgesia

Exclusion Criteria:

  • Contraindication to epidural anesthesia
  • Marked spinal deformities or a history of spinal instrumentation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01597466

Contacts
Contact: Morgan Le Guen, MD 46252442 ext 00331 m.leguen@hopital-foch.org

Locations
France
CHU Marseille Recruiting
Marseille, France, 13915
Contact: Marc Leone, MD    91 96 80 00 ext 00334    Marc.LEONE@ap-hm.fr   
Hopital Foch Recruiting
Suresnes, France, 92151
Contact: Morgan Le Guen, MD    46252442 ext 00331    m.leguen@hopital-foch.org   
Principal Investigator: Morgan Le Guen, MD         
Sponsors and Collaborators
Hopital Foch
Investigators
Principal Investigator: Morgan Le Guen, MD Hopital Foch
Study Chair: Marc Fischler, MD Hopital Foch
  More Information

No publications provided

Responsible Party: Hopital Foch
ClinicalTrials.gov Identifier: NCT01597466     History of Changes
Other Study ID Numbers: 2012/01
Study First Received: May 5, 2012
Last Updated: November 9, 2013
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

ClinicalTrials.gov processed this record on October 21, 2014